Gaudium IVF Closes Trading Window from Feb 27, 2026, pending Q3 FY26 Results
Gaudium IVF has closed its trading window for designated persons from February 27, 2026. This closure is effective until 48 hours after the announcement of the un-audited financial results for the quarter and nine months ended December 31, 2025. The board meeting date for results approval will be intimated separately.
The closure of the trading window is a standard regulatory requirement and does not directly impact the company's operations or financial performance. It is a procedural announcement.
The announcement is a routine compliance measure regarding the closure of the trading window, which is standard practice before financial results are announced. It does not contain any information that positively or negatively impacts the company's performance.
Gaudium IVF and Women Health Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal codes for insider trading and fair disclosure.
The trading window will remain shut from Friday, February 27, 2026, until 48 hours after the announcement of the un-audited financial results for the quarter and nine months period ended December 31, 2025.
The company will separately intimate the date of the Board of Directors' meeting, which will inter alia approve these financial results.
What to do with a filing like this
Gaudium IVF and Women Health Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gaudium IVF and Women Health Limited. Read the original for the full detail.